Google Website Translator Gadget

Tuesday, July 19, 2011

Forums on Race-Day Medication and the Future of Racing Top National HBPA Summer Convention Agenda

The National HBPA will kick off its 2011 summer convention at the Renaissance Seattle Hotel in Seattle, Washington this Thursday, July 21. The agenda for the four-day conference will be topped by speaker forums focused on both race-day medication and the future of racing. Both forums will be held on Friday, July 22.

On Friday morning, the National HBPA's Medication Committee will host a panel entitled, "The Scientific Case: Furosemide and the Prevention of Exercise-Induced Pulmonary Hommorrhage." Moderated by Medication Committee Chairman and Florida HBPA Executive Director Kent Stirling, the panel will explore scientific issues related to the use of furosemide (Salix/Lasix) for preventing EIPH in racehorses from various perspectives.

Panelists for the Medication Committee forum will include:

Dr. Paul S. Morley, DVM, PhD, Diplomate ACVIM, Professor of Epidemiology and Biosecurity, Clinical Science Department, Colorado State University

Dr. Don Shields, Equine Practitioner in Southern California, Founder of Winner’s Circle Ranch, an equine rehabilitation facility, Founder and CEO of Statison Medical, Clinical Assistant Professor of Veterinary Medicine, Western University of Health Sciences College of Veterinary Medicine

Dr. Thomas Tobin, Professor, Dept of Veterinary Science, Gluck Equine Research Center and Graduate Center for Toxicology, University of Kentucky & National HBPA Veterinary Advisor

Dr. Morley will speak about the South African furosemide study he co-authored. Dr. Tobin will give a presentation on the increased risk of injury to both horse and jockey if furosemide is banned, and Dr. Shields will report on the International Race Day Medication Summit, the proposed penalty guidelines for Bute, and his view of the furosemide situation.

Subsequent to the panel's comments, the National HBPA Medication Committee will discuss its position on both race-day use of furosemide and the proposed penalty guidelines for Bute.

On Friday afternoon, National HBPA President and Chairman Joe Santanna will moderate a "Vision of Racing's Future" panel. A group of forward thinkers will examine critical issues that will shape racing's future, including: technology, advanced deposit wagering (ADW), racing content and delivery, new forms of wagering, and more.

Panelists for the "Vision of Racing's Future" forum will include:

Charles Champion, Managing Partner Paladin Capital Partners and former Chairman and CEO, Youbet

Ron Crockett, President and lead partner of Emerald Downs Racetrack, Auburn, WA

Ron Maus, President, Washington HBPA, Founding Member of MRW Advisory, Seattle, WA

Frank Petramalo, Executive Director & Legal Counsel, Virginia HBPA

Alex Waldrop, President and CEO, National Thoroughbred Racing Association (NTRA)

The National HBPA's 2011 Summer Convention will continue through Sunday, July 24.

No comments:

Post a Comment